ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA approves novel treatment for highly drug-resistant forms of TB
August 20, 2019Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA), on 14 August 2019, for treating some of the most drug-resistant forms of tuberculosis (TB). -
DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association
February 24, 2019DBV Technologies Announces Publication of Detailed Phase III Trial Results Evaluating Viaskin Peanut as a Novel Treatment for Peanut Allergy in The Journal of the American Medical Association.
Pharma Sources Insight January 2025
